8-K - Acumen Pharmaceuticals, Inc. (0001576885) (Filer)
Published . Updated .
8-K - Acumen Pharmaceuticals filed an 8-K with the SEC on Oct 26 (a notice of a material company event).
Directly affected
- ABOS Acumen Pharmaceuticals-8.2% 6d
Named in this report.
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ABOS | -11.06% | +2.01% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-26 AccNo: 0001628280-26-067129 Size: 7 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Acumen Pharmaceuticals (ABOS) since “8-K - Acumen Pharmaceuticals, Inc. (0001576885) (Filer),” compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| Acumen Pharmaceuticals (ABOS) | three days earlier | +2.01% | final price |
| Acumen Pharmaceuticals (ABOS) | five days earlier | -11.06% | final price |
Who is named in “8-K - Acumen Pharmaceuticals, Inc. (0001576885) (Filer)”
Companies mentioned with this story
- ABOS Acumen Pharmaceuticals
In “8-K - Acumen Pharmaceuticals, Inc. (0001576885) (Filer),” Acumen Pharmaceuticals (ABOS) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> ABOS
How “8-K - Acumen Pharmaceuticals, Inc. (0001576885) (Filer)” reaches Acumen Pharmaceuticals (ABOS)
Acumen Pharmaceuticals (ABOS) is the company in “8-K - Acumen Pharmaceuticals, Inc. (0001576885) (Filer),” the 26 Oct 2026 this story story.
The link for Acumen Pharmaceuticals (ABOS) is this: SEC 8-K filing -> direct issuer disclosure -> ABOS
The price range for Acumen Pharmaceuticals (ABOS), and the dates in the story
ABOS traded between 2.70 and 3.01 across 2 sessions. The latest close on file is 2.90.
A simple score for Acumen Pharmaceuticals (ABOS)
14 out of 100
“8-K - Acumen Pharmaceuticals, Inc. (0001576885) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.